Vaccine to prevent type 1 diabetes in high-risk babies
Part of Hormones & metabolism, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This study tests whether a vaccine given to very young babies (3–4 months old) can prevent type 1 diabetes. It is designed for babies who have a high genetic risk and a family history of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 3 and 4 months old.
- Your baby must have a high genetic risk (over 10%) of developing type 1 diabetes before age 6.
- At least one parent or sibling must have type 1 diabetes.
- Your baby cannot already have diabetes or any serious health problem that affects the immune system.
- You must agree to not give your baby any other experimental treatments during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for people at high risk of developing type 1 diabetes (based on family history or blood markers) and follows them over time to understand disease development. The goal is to eventually prevent or delay type 1 diabetes in people who don't have it yet.
This trial checks whether giving a flu vaccine to people who were just diagnosed with type 1 diabetes affects their health and immune response. It may help doctors understand if flu vaccination is safe and useful soon after diagnosis.
This trial tests a new combination treatment for children who have been diagnosed with stage 1 type 1 diabetes, meaning they have some markers but do not yet need insulin. The treatment uses special immune cells (Treg cells) and an antibody (anti-CD20) to try to preserve the body's ability to make insulin.
This study tests whether a program of diet and activity advice for families can lower the risk of type 1 diabetes in infants who have a higher genetic chance of developing it. It aims to find simple, everyday ways to help protect your child.
This trial tests an investigational drug that may help preserve the body's ability to make insulin in people with type 1 diabetes. It aims to slow the progression of the disease and reduce the need for insulin injections.
This study tests a low dose of a drug that calms the immune system, followed by either another immune drug or a blood pressure medicine, to see if they can help preserve the body's ability to make insulin in people recently diagnosed with type 1 diabetes. It may help keep your own insulin production going longer.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.